205 related articles for article (PubMed ID: 29665511)
1. Advanced cutaneous squamous cell carcinoma: A retrospective analysis of patient profiles and treatment patterns-Results of a non-interventional study of the DeCOG.
Hillen U; Leiter U; Haase S; Kaufmann R; Becker J; Gutzmer R; Terheyden P; Krause-Bergmann A; Schulze HJ; Hassel J; Lahner N; Wollina U; Ziller F; Utikal J; Hafner C; Ulrich J; Machens HG; Weishaupt C; Hauschild A; Mohr P; Pföhler C; Maurer J; Wolff P; Windemuth-Kieselbach C; Schadendorf D; Livingstone E;
Eur J Cancer; 2018 Jun; 96():34-43. PubMed ID: 29665511
[TBL] [Abstract][Full Text] [Related]
2. Acantholytic squamous cell carcinoma is usually associated with hair follicles, not acantholytic actinic keratosis, and is not "high risk": Diagnosis, management, and clinical outcomes in a series of 115 cases.
Ogawa T; Kiuru M; Konia TH; Fung MA
J Am Acad Dermatol; 2017 Feb; 76(2):327-333. PubMed ID: 27889291
[TBL] [Abstract][Full Text] [Related]
3. Treatment of unresectable squamous cell carcinoma of the skin with epidermal growth factor receptor antibodies--a case series.
Eder J; Simonitsch-Klupp I; Trautinger F
Eur J Dermatol; 2013; 23(5):658-62. PubMed ID: 24135559
[TBL] [Abstract][Full Text] [Related]
4. An evolving paradigm for the workup and management of high-risk cutaneous squamous cell carcinoma.
O'Bryan K; Sherman W; Niedt GW; Taback B; Manolidis S; Wang A; Ratner D
J Am Acad Dermatol; 2013 Oct; 69(4):595-602.e1. PubMed ID: 23871719
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of 122 advanced-stage cutaneous squamous cell carcinomas by comprehensive genomic profiling opens the door for new routes to targeted therapies.
Al-Rohil RN; Tarasen AJ; Carlson JA; Wang K; Johnson A; Yelensky R; Lipson D; Elvin JA; Vergilio JA; Ali SM; Suh J; Miller VA; Stephens PJ; Ganesan P; Janku F; Karp DD; Subbiah V; Mihm MC; Ross JS
Cancer; 2016 Jan; 122(2):249-57. PubMed ID: 26479420
[TBL] [Abstract][Full Text] [Related]
6. A systematic review of clinical outcomes for patients diagnosed with skin cancer spinal metastases.
Goodwin CR; Sankey EW; Liu A; Elder BD; Kosztowski T; Lo SF; Fisher CG; Clarke MJ; Gokaslan ZL; Sciubba DM
J Neurosurg Spine; 2016 May; 24(5):837-49. PubMed ID: 26544595
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the AJCC N staging system in mucosal and cutaneous squamous head and neck cancer.
Brunner M; Ng BC; Veness MJ; Clark JR
Laryngoscope; 2014 Jul; 124(7):1598-602. PubMed ID: 24307576
[TBL] [Abstract][Full Text] [Related]
8. Analysis of risk factors determining prognosis of cutaneous squamous-cell carcinoma: a prospective study.
Brantsch KD; Meisner C; Schönfisch B; Trilling B; Wehner-Caroli J; Röcken M; Breuninger H
Lancet Oncol; 2008 Aug; 9(8):713-20. PubMed ID: 18617440
[TBL] [Abstract][Full Text] [Related]
9. Impact of High Age and Comorbidity on Management Decisions and Adherence to Guidelines in Patients with Keratinocyte Skin Cancer.
Lubeek SFK; Michielsens CAJ; Borgonjen RJ; Bronkhorst EM; van de Kerkhof PCM; Gerritsen MP
Acta Derm Venereol; 2017 Jul; 97(7):825-829. PubMed ID: 28417143
[TBL] [Abstract][Full Text] [Related]
10. Prospective study of definitive chemoradiation in locally or regionally advanced squamous cell carcinoma of the skin.
Nottage MK; Lin C; Hughes BG; Kenny L; Smith DD; Houston K; Francesconi A
Head Neck; 2017 Apr; 39(4):679-683. PubMed ID: 28032670
[TBL] [Abstract][Full Text] [Related]
11. The occurrence of non-melanoma malignant skin lesions and non-cutaneous squamous-cell carcinoma among metastatic melanoma patients: an observational cohort study in Denmark.
Li H; Pedersen L; Nørgaard M; Ulrichsen SP; Thygesen SK; Nelson JJ
BMC Cancer; 2016 May; 16():295. PubMed ID: 27141983
[TBL] [Abstract][Full Text] [Related]
12. Cisplatin and Cetuximab Treatment for Metastatic Cutaneous Squamous Cell Carcinoma: A Systematic Review.
Trodello C; Pepper JP; Wong M; Wysong A
Dermatol Surg; 2017 Jan; 43(1):40-49. PubMed ID: 27618393
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological analysis of ten patients with metaplastic squamous cell carcinoma of the breast.
Honda M; Saji S; Horiguchi S; Suzuki E; Aruga T; Horiguchi K; Kitagawa D; Sekine S; Funata N; Toi M; Kuroi K
Surg Today; 2011 Mar; 41(3):328-32. PubMed ID: 21365411
[TBL] [Abstract][Full Text] [Related]
14. Managing patients with cutaneous squamous cell carcinoma metastatic to the axilla or groin lymph nodes.
Goh A; Howle J; Hughes M; Veness MJ
Australas J Dermatol; 2010 May; 51(2):113-7. PubMed ID: 20546217
[TBL] [Abstract][Full Text] [Related]
15. Clinical outcomes among unresectable, locally advanced, and metastatic cutaneous squamous cell carcinoma patients treated with systemic therapy.
Cowey CL; Robert NJ; Espirito JL; Davies K; Frytak J; Lowy I; Fury MG
Cancer Med; 2020 Oct; 9(20):7381-7387. PubMed ID: 32578965
[TBL] [Abstract][Full Text] [Related]
16. Risk of cutaneous squamous cell carcinoma after treatment of basal cell carcinoma with vismodegib.
Bhutani T; Abrouk M; Sima CS; Sadetsky N; Hou J; Caro I; Chren MM; Arron ST
J Am Acad Dermatol; 2017 Oct; 77(4):713-718. PubMed ID: 28780365
[TBL] [Abstract][Full Text] [Related]
17. [Clinical characteristics of malignant tumours originating in the external ear].
Gallegos-Hernández JF; Martínez-Méndez MÁ; Ábrego-Vázquez JA; Hernández-Sanjuan M; Minauro-Muñoz GG; Ortiz-Maldonado AL
Cir Cir; 2015; 83(6):473-7. PubMed ID: 26183026
[TBL] [Abstract][Full Text] [Related]
18. Cutaneous Squamous Cell Carcinoma: A Review of High-Risk and Metastatic Disease.
Burton KA; Ashack KA; Khachemoune A
Am J Clin Dermatol; 2016 Oct; 17(5):491-508. PubMed ID: 27358187
[TBL] [Abstract][Full Text] [Related]
19. Systemic Therapy in Advanced Cutaneous Squamous Cell Carcinoma (CSCC): The Roswell Park Experience and a Review of the Literature.
Jarkowski A; Hare R; Loud P; Skitzki JJ; Kane JM; May KS; Zeitouni NC; Nestico J; Vona KL; Groman A; Khushalani NI
Am J Clin Oncol; 2016 Dec; 39(6):545-548. PubMed ID: 24879468
[TBL] [Abstract][Full Text] [Related]
20. Safety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-012): an open-label, multicentre, phase 1b trial.
Seiwert TY; Burtness B; Mehra R; Weiss J; Berger R; Eder JP; Heath K; McClanahan T; Lunceford J; Gause C; Cheng JD; Chow LQ
Lancet Oncol; 2016 Jul; 17(7):956-965. PubMed ID: 27247226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
